Novo Nordisk News | Latest News - 쮸떴눈첵

Novo Nordisk

In the last 2 hours

The Irish Times18:23

In the last 8 hours

Benzinga12:30

Law36012:16

Earlier today

Hindustan Times11:26

FiercePharma06:39

Benzinga05:36

Yahoo! US04:50

The Motley Fool02:47

Forbes00:53

Yahoo! UK & Ireland00:33

Yesterday

London South East22:48 17-Apr-25

NBC Connecticut22:13 17-Apr-25

Korea Biomedical Review15:03 17-Apr-25

Fox News07:55 17-Apr-25

NPR06:07 17-Apr-25

Vice (US)05:02 17-Apr-25

Pharmaceutical Technology01:18 17-Apr-25

In the last 7 days

The Kansas City Star15:00 16-Apr-25

KCBD, Texas13:23 16-Apr-25

KCRG TV 9, Iowa12:26 16-Apr-25

Law36011:04 16-Apr-25

ABC7 / WLS-TV11:02 16-Apr-25

PR Newswire (Press Release)07:22 16-Apr-25

Benzinga06:31 16-Apr-25

Black Enterprise06:03 16-Apr-25

Benzinga05:20 16-Apr-25

Zacks01:03 16-Apr-25

The Motley Fool00:23 16-Apr-25

Business Wire (Press Release)23:01 15-Apr-25

Business Wire (Press Release)19:34 15-Apr-25

Northwest Arkansas Democrat-Gazette17:36 15-Apr-25

Bernama16:02 15-Apr-25

Campaign Brief13:41 15-Apr-25

WHDH-TV, Massachusetts12:09 15-Apr-25

NBC Connecticut10:38 15-Apr-25

B&T Marketing & Media09:48 15-Apr-25

Law36009:26 15-Apr-25

UPI08:47 15-Apr-25

Bloomberg Law02:59 15-Apr-25

Science|Business02:28 15-Apr-25

Investing.com UK01:50 15-Apr-25

PR Newswire (Press Release)01:49 15-Apr-25

The Motley Fool01:18 15-Apr-25

PR Newswire (Press Release)00:59 15-Apr-25

Yahoo! US00:52 15-Apr-25

The Economic Times00:19 15-Apr-25

AdNews00:09 15-Apr-25

Gulf News23:04 14-Apr-25

pharmaphorum22:19 14-Apr-25

Motley Fool (UK)16:33 13-Apr-25

The Economic Times10:45 12-Apr-25

Scrip Pharma Intelligence01:07 12-Apr-25

Zacks00:44 12-Apr-25

Korea Biomedical Review19:03 11-Apr-25

Law36011:47 11-Apr-25

FoodNavigator.com02:04 11-Apr-25

Science News Online01:03 11-Apr-25

In the last month

Zacks20:03 10-Apr-25

Yahoo! UK & Ireland19:58 10-Apr-25

Zacks08:01 10-Apr-25

Pharmaceutical Online04:07 10-Apr-25

The Motley Fool00:03 10-Apr-25

Pharmaceutical Technology22:00 9-Apr-25

ENDPOINTS20:56 9-Apr-25

Morningstar20:44 9-Apr-25

Fortune20:41 9-Apr-25

Law36010:26 9-Apr-25

MorningStar.com09:34 9-Apr-25

Bloomberg Law09:08 9-Apr-25

Courthouse News04:15 9-Apr-25

The Economic Times02:46 9-Apr-25

Global Construction Review02:31 9-Apr-25

ENDPOINTS01:37 9-Apr-25

Zacks01:18 9-Apr-25

Zacks00:07 9-Apr-25

FiercePharma23:57 8-Apr-25

Radio Tamazuj19:29 8-Apr-25

World Food Programme (Press Release)18:07 8-Apr-25

BioWorld07:02 8-Apr-25

Agencia Brasil05:07 8-Apr-25

TIME05:00 8-Apr-25

Benzinga04:56 8-Apr-25

TipRanks04:51 8-Apr-25

Global News03:42 8-Apr-25

The Rio Times02:58 8-Apr-25

Yahoo! US01:36 8-Apr-25

Healthcare Dive00:29 8-Apr-25

Pharmaceutical Technology21:01 7-Apr-25

pharmaphorum20:35 7-Apr-25

The Times of India05:17 7-Apr-25

The Hindu Business Line23:29 6-Apr-25

Toronto Star08:53 6-Apr-25

The News International02:11 6-Apr-25

Quartz00:09 6-Apr-25

Bangkok Post11:45 5-Apr-25

NBC Connecticut09:51 5-Apr-25

Yahoo! UK & Ireland08:25 5-Apr-25

Forbes02:08 5-Apr-25

ENDPOINTS22:03 4-Apr-25

PR Newswire (Press Release)21:22 4-Apr-25

Korea Biomedical Review21:22 4-Apr-25

Manufacturing Chemist21:21 4-Apr-25

Mint02:43 4-Apr-25

Invezz01:03 4-Apr-25

TipRanks21:34 3-Apr-25

Yahoo! UK & Ireland17:42 3-Apr-25

GlobeNewswire (Press Release)17:03 3-Apr-25

Business Wire (Press Release)04:34 3-Apr-25

Quartz02:13 3-Apr-25

Benzinga00:20 3-Apr-25

Labiotech00:09 3-Apr-25

Financial Mail23:57 2-Apr-25

Invezz22:07 2-Apr-25

Vietnam Investment Review20:34 2-Apr-25

Financial Mail19:22 2-Apr-25

view more headlines

18 Apr 18:23

About our Novo Nordisk news

Latest news on Novo Nordisk, a global healthcare company focused on diabetes care, obesity treatment, and other serious chronic diseases. Get updates on Novo Nordisk's products, research, financial performance, and stock price.

Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark. Founded in 1923, the company has grown to become a global leader in diabetes care, with a strong presence in the fields of hemophilia, growth hormone therapy, and obesity treatment. Novo Nordisk's key products include insulin analogs like Tresiba and Levemir, GLP-1 receptor agonists such as Victoza and Ozempic, and obesity drugs like Saxenda and Wegovy.

Stay informed about the latest developments in Novo Nordisk's research and development pipeline, including updates on clinical trials, regulatory approvals, and new product launches. Our feed covers the company's ongoing efforts to innovate and improve treatments for diabetes, obesity, and other metabolic disorders, such as the development of oral semaglutide and the exploration of novel drug targets.

In addition to product news, our Novo Nordisk feed keeps you updated on the company's financial performance, including quarterly earnings reports, sales figures, and market share data. We also cover key events and announcements that may impact Novo Nordisk's stock price (NYSE: NVO), such as strategic partnerships, acquisitions, and leadership changes.

Beyond the business aspects, our feed highlights Novo Nordisk's commitment to corporate social responsibility and sustainability. From initiatives to improve access to diabetes care in developing countries to efforts to reduce the company's environmental footprint, we provide a comprehensive view of Novo Nordisk's impact on global health and society.

As the prevalence of diabetes and obesity continues to rise worldwide, Novo Nordisk plays a crucial role in addressing these global health challenges. Our 쮸떴눈첵 feed on Novo Nordisk brings you the most relevant and up-to-date information from reliable sources, helping you stay informed about this innovative and influential healthcare company.

쮸떴눈첵

Novo Nordisk

About our Novo Nordisk news

Pharmaceuticals Top Stories

Business Top Stories